...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthetic Access to Cannabidiol and Analogs as Active Pharmaceutical Ingredients
【24h】

Synthetic Access to Cannabidiol and Analogs as Active Pharmaceutical Ingredients

机译:Synthetic Access to Cannabidiol and Analogs as Active Pharmaceutical Ingredients

获取原文
获取原文并翻译 | 示例
           

摘要

Cannabinoids have surely been one of the most widely self-administered drugs other than caffeine. The U.S. FDA recently approved one cannabinoid-based drug whose active pharmaceutical ingredient (API) is cannabidiol (CBD). The long history of individual use of cannabis for a wide range of conditions has sparked great interest in other uses of CBD, in ethical drugs and botanical supplements as well as in foods and nonprescription wellness products. CBD may be sourced from cannabis plants but can also be prepared synthetically, the topic of this review.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号